Trinad Chakraborty Selected Research

Listeriosis (Listeria Infection)

10/2019	The secRNome of Listeria monocytogenes Harbors Small Noncoding RNAs That Are Potent Inducers of Beta Interferon.
4/2014	Crystal structure of listeriolysin O reveals molecular details of oligomerization and pore formation.
11/2010	Gram-positive pathogenic bacteria induce a common early response in human monocytes.
7/2010	Antibody targeting the ferritin-like protein controls Listeria infection.
1/2010	Galleria mellonella as a model system for studying Listeria pathogenesis.
12/2006	Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection.
9/2005	The cholesterol-dependent cytolysin listeriolysin O aggregates rafts via oligomerization.
12/2002	Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Trinad Chakraborty Research Topics

Disease

47	Infections 03/2022 - 12/2002
8	Listeriosis (Listeria Infection) 10/2019 - 12/2002
7	Inflammation (Inflammations) 01/2021 - 09/2005
6	Pneumonia (Pneumonitis) 01/2021 - 03/2006
6	Edema (Dropsy) 11/2018 - 02/2012
4	Neoplasms (Cancer) 01/2022 - 01/2012
4	Lung Injury 01/2021 - 03/2010
4	Autolysis 01/2021 - 12/2003
4	Lung Diseases (Lung Disease) 01/2020 - 04/2005
4	Acute Lung Injury 01/2018 - 01/2010
4	Bacterial Infections (Bacterial Infection) 01/2017 - 12/2008
3	Periodontitis 01/2022 - 12/2011
3	Pulmonary Edema 11/2018 - 01/2010
3	Wounds and Injuries (Trauma) 03/2014 - 05/2008
3	Communicable Diseases (Infectious Diseases) 07/2013 - 02/2003
3	Hypersensitivity (Allergy) 01/2009 - 09/2005
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 01/2022
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 11/2016
2	Pneumococcal Pneumonia 01/2021 - 10/2012
2	Hypoxia (Hypoxemia) 01/2021 - 03/2010
2	Virus Diseases (Viral Diseases) 10/2019 - 01/2019
2	Necrosis 01/2018 - 01/2013
2	Pathologic Processes 01/2017 - 01/2012
2	Epididymitis 09/2015 - 03/2014
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2013 - 01/2010
2	Diarrhea 06/2009 - 01/2009
1	Hypotension (Low Blood Pressure) 01/2022
1	Cystitis 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	COVID-19 01/2021
1	Acute Chest Syndrome 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Community-Acquired Infections 12/2020
1	Bronchopulmonary Dysplasia 07/2020
1	Disease Progression 01/2020
1	Human Influenza (Influenza) 01/2019
1	Neonatal Sepsis 10/2018
1	Hemolysis 10/2018

Drug/Important Bio-Agent (IBA)

13	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 12/2003
11	CytokinesIBA 01/2021 - 09/2005
10	Virulence Factors (Pathogenicity Factors)IBA 01/2022 - 12/2010
9	Streptococcus pneumoniae plY proteinIBA 01/2021 - 01/2010
9	Proteins (Proteins, Gene)FDA Link 09/2014 - 12/2003
7	Listeria monocytogenes hlyA protein (listeriolysin O)IBA 01/2017 - 12/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2008
4	LectinsIBA 01/2021 - 09/2005
4	beta-Lactamases (beta-Lactamase)IBA 10/2018 - 03/2009
4	ChemokinesIBA 09/2015 - 09/2005
4	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2009 - 04/2005
3	RNA (Ribonucleic Acid)IBA 03/2022 - 10/2019
3	Bacterial ToxinsIBA 01/2020 - 01/2013
3	pepBs1-Ac peptideIBA 11/2018 - 01/2010
3	Pharmaceutical PreparationsIBA 06/2015 - 06/2011
3	Interleukin-6 (Interleukin 6)IBA 03/2014 - 02/2003
3	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 11/2005
2	LigandsIBA 01/2021 - 08/2008
2	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021 - 01/2010
2	Biological ProductsIBA 01/2021 - 03/2015
2	Carbapenems (Carbapenem Antibiotics)IBA 12/2020 - 01/2018
2	carbapenemaseIBA 12/2020 - 01/2019
2	InterferonsIBA 10/2019 - 11/2012
2	CholesterolIBA 01/2018 - 07/2013
2	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 11/2016 - 07/2013
2	CPG-oligonucleotideIBA 10/2016 - 09/2015
2	Ribosomal DNA (rDNA)IBA 09/2015 - 11/2003
2	Protein Kinases (Protein Kinase)IBA 01/2015 - 12/2002
2	Protein Kinase CIBA 09/2014 - 01/2010
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2014 - 12/2006
2	LipopolysaccharidesIBA 11/2013 - 01/2013
2	Epithelial Sodium ChannelsIBA 07/2013 - 01/2010
2	ChloridesIBA 10/2011 - 06/2009
2	Ferritins (Ferritin)IBA 07/2010 - 04/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2010 - 01/2010
2	Interleukin-8 (Interleukin 8)IBA 12/2008 - 02/2003
2	AntigensIBA 04/2006 - 11/2005
1	C-Reactive ProteinIBA 01/2022
1	Fosfomycin FDA Link 01/2022
1	MacrolidesIBA 01/2021
1	Penicillins (Penicillin)FDA Link 01/2021
1	InflammasomesIBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021
1	ExotoxinsIBA 01/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Oxygen (Dioxygen)IBA 07/2020
1	Interferon Type IIBA 10/2019
1	VaccinesIBA 01/2019
1	Viral AntigensIBA 01/2019
1	Peptides (Polypeptides)IBA 11/2018
1	AgarIBA 10/2018
1	CatalaseIBA 10/2018
1	Oxidoreductases (Dehydrogenase)IBA 10/2018
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2018
1	LactamsIBA 01/2018

Therapy/Procedure

7	Therapeutics 01/2022 - 12/2003
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 07/2020
2	Lung Transplantation 11/2013 - 03/2010
1	Salvage Therapy 01/2022